February 20, 2023
Mitsubishi Chemical Group has upwardly revised its annual earnings forecast for the year ending March 2023 after a decision in favor of the company in arbitration proceedings over royalty payments tied to the multiple sclerosis drug Gilenya (fingolimod). According to...read more